SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vertex Pharmaceuticals (VRTX) -- Ignore unavailable to you. Want to Upgrade?


To: Spekulatius who wrote (584)4/25/2002 2:00:27 AM
From: scaram(o)uche  Read Replies (1) | Respond to of 1169
 
I believe that the Amgen trial was very large, and achieved only modest results on the "Enbrel" scale. I therefore wasn't expecting much, and this sounds OK to me. A 20% haircut?

Yes, I realize that an ICE inhibitor is not equivalent to an IL-1 receptor antagonist.

Again..... I have no interest, apart from my interest.

:-)